PULMATRIX, INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
PULMATRIX, INC. (PULM) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $3.59 million as of 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2022-03-29
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $3.59M.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $11.17M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $18.67M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $99.23M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2021-12-31 | $3.59M 10-K · filed 2022-03-29 |
| 2020-12-31 | $11.17M 10-K · filed 2021-03-23 |
| 2019-12-31 | $18.67M 10-K · filed 2020-03-26 |
| 2018-12-31 | $99.23M 10-K · filed 2019-02-19 |
| 2017-12-31 | $81.45M 10-K · filed 2018-03-13 |
| 2016-12-31 | $68.62M 10-K · filed 2017-03-10 |
| 2015-12-31 | $61.82M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |